Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease
Related Experiment Videos
1Cardiac Health Institute, 173 Shaftsbury Road, Eastwood, NSW 2122, Australia.
Insights
Dietary supplement use is common in cardiac patients, with many unaware of potential interactions with prescription medications. Healthcare providers should proactively inquire about supplement use to ensure patient safety and optimize cardiovascular care.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Cardiovascular disease is a leading cause of mortality globally.
- Dietary supplement use is prevalent across various populations.
- The interaction between dietary supplements and cardiovascular medications is not fully understood.
Purpose of the Study:
- To systematically review and describe the prevalence of dietary supplement use among patients with cardiovascular risk factors or established cardiovascular disease.
- To identify the types of supplements commonly used and the reasons for their use.
- To assess the extent of concurrent use of supplements with prescription medications and physician awareness.
Main Methods:
- A systematic search of multiple bibliographic databases (Medline, EMBASE, CINAHL, AMED, Meditext, H&S, IPA) was performed.
- Studies investigating supplement use in individuals with cardiovascular risk factors or disease were included.
- Twenty studies meeting the review criteria were analyzed.
Main Results:
- Dietary supplements were used by a median of 36% of cardiac patients.
- Vitamin/mineral supplements were used by 36%, and herbal supplements by 12%.
- A significant proportion of patients (16-64%) used supplements with prescription drugs, often without physician awareness (39-95%).
Conclusions:
- Dietary supplement consumption is common in patients with cardiovascular disease.
- Concurrent use of supplements with prescription medications is frequent, highlighting potential safety concerns.
- Physicians should be more proactive in inquiring about supplement use to improve patient management and safety.
Abstract:
Systematic search of bibliographic databases was conducted to describe the prevalence of dietary supplement use in cardiac patients. Included for review were studies that investigated supplement use in people with cardiovascular risk factors or proven cardiovascular disease. Databases searched were Medline, EMBASE, CINAHL, AMED, Meditext, H&S and IPA. Over five hundred articles were retrieved and twenty studies met the criteria for this review. Dietary supplements were taken by a median 36% (interquartile range: 26-42%) of cardiac patients; 36% (IQR 18-43%) reported taking a vitamin/mineral supplement and 12% (IQR 7-21%) used herbal supplements. Many users indicated that supplements were taken specifically for heart health and 16-64% of users reported using supplements alongside prescription medications. However 39-95% of treating physicians were unaware of patients' supplement use. Dietary supplement use in patients with cardiovascular disease appears common, as does the concurrent use of supplements with prescription medicines. This information is often not communicated to doctors and treating physicians may need to be more proactive in asking about supplement use.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atherosclerosis III: Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease IV: Preventive Measures
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...